bisoprolol has been researched along with Muscular Dystrophy, Duchenne in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
| Excerpt | Relevance | Reference |
|---|---|---|
| " After a slow increase in the dosage to 10 mg enalapril/day and 2." | 1.36 | Recovery of systolic dysfunction in duchenne muscular dystrophy due to the point mutation c.4213C>T. ( Finsterer, J; Holinski-Feder, E; Stöllberger, C, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finsterer, J | 1 |
| Stöllberger, C | 1 |
| Holinski-Feder, E | 1 |
1 other study available for bisoprolol and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Recovery of systolic dysfunction in duchenne muscular dystrophy due to the point mutation c.4213C>T.
Topics: Adult; Antihypertensive Agents; Bisoprolol; Drug Therapy, Combination; Enalapril; Humans; Male; Musc | 2010 |